SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-219972
Filing Date
2019-08-13
Accepted
2019-08-13 16:17:03
Documents
58
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d766386d10q.htm 10-Q 431515
2 EX-10.1 d766386dex101.htm EX-10.1 31507
3 EX-31.1 d766386dex311.htm EX-31.1 9691
4 EX-31.2 d766386dex312.htm EX-31.2 9692
5 EX-32.1 d766386dex321.htm EX-32.1 5100
  Complete submission text file 0001193125-19-219972.txt   3192488

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT logc-20190630.xml EX-101.INS 610668
7 XBRL TAXONOMY EXTENSION SCHEMA logc-20190630.xsd EX-101.SCH 33025
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE logc-20190630_cal.xml EX-101.CAL 32021
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE logc-20190630_def.xml EX-101.DEF 233891
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE logc-20190630_lab.xml EX-101.LAB 278163
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE logc-20190630_pre.xml EX-101.PRE 261295
Mailing Address 99 ERIE STREET CAMBRIDGE MA 02139
Business Address 99 ERIE STREET CAMBRIDGE MA 02139 617-245-0399
LogicBio Therapeutics, Inc. (Filer) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38707 | Film No.: 191020821
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1